U.S. markets closed
  • S&P 500

    4,419.15
    +18.51 (+0.42%)
     
  • Dow 30

    35,084.53
    +153.60 (+0.44%)
     
  • Nasdaq

    14,778.26
    +15.68 (+0.11%)
     
  • Russell 2000

    2,240.03
    +15.07 (+0.68%)
     
  • Crude Oil

    73.39
    -0.23 (-0.31%)
     
  • Gold

    1,833.60
    -2.20 (-0.12%)
     
  • Silver

    25.61
    -0.17 (-0.67%)
     
  • EUR/USD

    1.1898
    +0.0001 (+0.01%)
     
  • 10-Yr Bond

    1.2690
    +0.0080 (+0.63%)
     
  • GBP/USD

    1.3972
    +0.0014 (+0.10%)
     
  • USD/JPY

    109.4200
    -0.0410 (-0.04%)
     
  • BTC-USD

    39,934.12
    +154.69 (+0.39%)
     
  • CMC Crypto 200

    935.12
    +4.76 (+0.51%)
     
  • FTSE 100

    7,078.42
    +61.79 (+0.88%)
     
  • Nikkei 225

    27,782.42
    +200.76 (+0.73%)
     

Embraer Posts Smaller-Than-Feared Quarterly Loss; Shares Pop 7%

·1 min read

Shares of Embraer SA jumped 6.8% after the Brazilian aerospace conglomerate reported a better-than-expected loss in the fourth quarter and surpassed analysts’ expectations for revenues.

Embraer (ERJ) incurred a loss of $0.07 per share in 4Q, compared to the $0.32 loss per share estimated by analysts and $0.81 per share reported in the prior-year quarter.

Total revenue came in at $1.84 billion, topping analysts’ expectations of $1.66 billion but declining 11.7% year-over-year. Growth in the defense & security segment was fully mitigated by revenue declines in commercial aviation, executive jets, and services & support segments.

The company’s adjusted EBITDA was $145.6 million in the quarter, up from $65.8 million in the same quarter last year. In 4Q, Embraer delivered 28 commercial jets and 43 executive jets. (See Embraer stock analysis on TipRanks)

Cowen & Co. analyst Cai Rumohr maintained a Hold rating and a price target of $7 (34.5% downside potential) based on the company’s “better than expected” 4Q results.

Overall, the stock has a Moderate Sell consensus rating based on 2 Holds versus 1 Sell. The average analyst price target of $6 implies 43.8% downside potential from current levels.

Related News:
FedEx Posts Better-Than-Expected 3Q Results As Sales Outperform; Shares Gain 4.4%
Ollie’s 4Q Results Beat Analysts’ Expectations As Sales Pick Up; Shares Gain After-Hours
Kiniksa Wins FDA Nod For ARCALYST Injection therapy; Shares Pop After-Hours

More recent articles from Smarter Analyst: